María José
Calasanz Abinzano
Catedrática de Universidad
University Hospital of Lausanne
Lausana, SuizaPublicaciones en colaboración con investigadores/as de University Hospital of Lausanne (3)
2022
-
Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patients
Haematologica, Vol. 107, Núm. 3, pp. 593-603
-
TP53 Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex Karyotype
Cancers, Vol. 14, Núm. 15
2011
-
Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q
Leukemia, Vol. 25, Núm. 1, pp. 110-120